Tag Archive for: apalutamide
Apalutamide Shows Promising Survival Outcomes in Metastatic Castration-Sensitive Prostate Cancer: A Real-World Analysis
/in Observational, Post-hoc, Retrospective studies/by MaxEarly PSA Response as a Predictor and Mediator of Treatment Efficacy in Metastatic Hormone Sensitive Prostate Cancer
/in Post-hoc, Retrospective studies/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy CAR-T clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus Pluvicto prostate cancer protac PSMA PSMA-targeted therapy radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Actinium‑225 NTSR1‑Targeted Radiopharmaceutical SKL35501 January 26, 2026
- Newsletter 4/2026 January 25, 2026
- Recent Discovery on tRNA Halves in Prostate Cancer January 24, 2026
- ARREST Trial: Precision Radiation Boosts to Fix 177Lu-PSMA’s 50% Failure Rate January 23, 2026